nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—HTR3A—enteric nervous system—Crohn's disease	0.0526	0.21	CbGeAlD
Mirtazapine—HTR3A—myenteric nerve plexus—Crohn's disease	0.0399	0.159	CbGeAlD
Mirtazapine—HTR7—enteric nervous system—Crohn's disease	0.034	0.136	CbGeAlD
Mirtazapine—HTR7—myenteric nerve plexus—Crohn's disease	0.0258	0.103	CbGeAlD
Mirtazapine—HTR2A—enteric nervous system—Crohn's disease	0.0212	0.0848	CbGeAlD
Mirtazapine—HTR2A—myenteric nerve plexus—Crohn's disease	0.0161	0.0642	CbGeAlD
Mirtazapine—HRH3—digestive system—Crohn's disease	0.0063	0.0252	CbGeAlD
Mirtazapine—HTR7—mouth—Crohn's disease	0.00441	0.0176	CbGeAlD
Mirtazapine—HTR3A—digestive system—Crohn's disease	0.00302	0.0121	CbGeAlD
Mirtazapine—HTR2B—smooth muscle tissue—Crohn's disease	0.00289	0.0115	CbGeAlD
Mirtazapine—HTR2B—skin of body—Crohn's disease	0.00285	0.0114	CbGeAlD
Mirtazapine—HTR7—epithelium—Crohn's disease	0.00257	0.0103	CbGeAlD
Mirtazapine—ADRA1A—epithelium—Crohn's disease	0.00248	0.00989	CbGeAlD
Mirtazapine—HTR7—smooth muscle tissue—Crohn's disease	0.00247	0.00988	CbGeAlD
Mirtazapine—SLC6A4—digestive system—Crohn's disease	0.0023	0.00919	CbGeAlD
Mirtazapine—HTR2B—digestive system—Crohn's disease	0.00228	0.00911	CbGeAlD
Mirtazapine—ADRA2C—mammalian vulva—Crohn's disease	0.00205	0.00817	CbGeAlD
Mirtazapine—HTR7—digestive system—Crohn's disease	0.00195	0.0078	CbGeAlD
Mirtazapine—HRH1—epithelium—Crohn's disease	0.00192	0.00766	CbGeAlD
Mirtazapine—ADRA1A—lymphoid tissue—Crohn's disease	0.00191	0.00762	CbGeAlD
Mirtazapine—HRH1—smooth muscle tissue—Crohn's disease	0.00185	0.00738	CbGeAlD
Mirtazapine—HRH1—mammalian vulva—Crohn's disease	0.00166	0.00664	CbGeAlD
Mirtazapine—ADRA2A—mammalian vulva—Crohn's disease	0.00163	0.00652	CbGeAlD
Mirtazapine—HTR2A—epithelium—Crohn's disease	0.0016	0.00639	CbGeAlD
Mirtazapine—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.00159	0.00335	CcSEcCtD
Mirtazapine—Migraine—Mesalazine—Crohn's disease	0.00158	0.00334	CcSEcCtD
Mirtazapine—Affect lability—Mesalazine—Crohn's disease	0.00158	0.00334	CcSEcCtD
Mirtazapine—CYP1A2—digestive system—Crohn's disease	0.00156	0.00622	CbGeAlD
Mirtazapine—Glaucoma—Prednisone—Crohn's disease	0.00155	0.00328	CcSEcCtD
Mirtazapine—Face oedema—Mesalazine—Crohn's disease	0.00155	0.00327	CcSEcCtD
Mirtazapine—HTR2A—smooth muscle tissue—Crohn's disease	0.00154	0.00616	CbGeAlD
Mirtazapine—Mood swings—Mesalazine—Crohn's disease	0.00152	0.00321	CcSEcCtD
Mirtazapine—Arthralgia—Mercaptopurine—Crohn's disease	0.00152	0.0032	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00151	0.00318	CcSEcCtD
Mirtazapine—Pancreatitis—Azathioprine—Crohn's disease	0.00149	0.00316	CcSEcCtD
Mirtazapine—Memory impairment—Prednisone—Crohn's disease	0.00149	0.00315	CcSEcCtD
Mirtazapine—Liver function test abnormal—Mesalazine—Crohn's disease	0.00148	0.00313	CcSEcCtD
Mirtazapine—CYP2C9—digestive system—Crohn's disease	0.00148	0.00591	CbGeAlD
Mirtazapine—Dry skin—Mesalazine—Crohn's disease	0.00147	0.00311	CcSEcCtD
Mirtazapine—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00147	0.0031	CcSEcCtD
Mirtazapine—HRH1—digestive system—Crohn's disease	0.00146	0.00582	CbGeAlD
Mirtazapine—Oedema—Mercaptopurine—Crohn's disease	0.00145	0.00307	CcSEcCtD
Mirtazapine—Pancytopenia—Azathioprine—Crohn's disease	0.00145	0.00306	CcSEcCtD
Mirtazapine—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00145	0.00305	CcSEcCtD
Mirtazapine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00142	0.00301	CcSEcCtD
Mirtazapine—Petechiae—Prednisone—Crohn's disease	0.00142	0.00301	CcSEcCtD
Mirtazapine—Gastritis—Mesalazine—Crohn's disease	0.00142	0.003	CcSEcCtD
Mirtazapine—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00142	0.00299	CcSEcCtD
Mirtazapine—Skin disorder—Mercaptopurine—Crohn's disease	0.00141	0.00298	CcSEcCtD
Mirtazapine—Abdominal distension—Mesalazine—Crohn's disease	0.0014	0.00295	CcSEcCtD
Mirtazapine—Acne—Prednisone—Crohn's disease	0.00139	0.00294	CcSEcCtD
Mirtazapine—Asthma—Mesalazine—Crohn's disease	0.00139	0.00293	CcSEcCtD
Mirtazapine—Influenza—Mesalazine—Crohn's disease	0.00139	0.00293	CcSEcCtD
Mirtazapine—Anorexia—Mercaptopurine—Crohn's disease	0.00139	0.00293	CcSEcCtD
Mirtazapine—Eosinophilia—Mesalazine—Crohn's disease	0.00137	0.0029	CcSEcCtD
Mirtazapine—Pneumonia—Azathioprine—Crohn's disease	0.00137	0.00289	CcSEcCtD
Mirtazapine—Delirium—Prednisone—Crohn's disease	0.00136	0.00287	CcSEcCtD
Mirtazapine—Pancreatitis—Mesalazine—Crohn's disease	0.00136	0.00287	CcSEcCtD
Mirtazapine—Angina pectoris—Mesalazine—Crohn's disease	0.00135	0.00286	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00135	0.00285	CcSEcCtD
Mirtazapine—Bronchitis—Mesalazine—Crohn's disease	0.00133	0.00282	CcSEcCtD
Mirtazapine—Amenorrhoea—Prednisone—Crohn's disease	0.00133	0.00281	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00132	0.0028	CcSEcCtD
Mirtazapine—Pancytopenia—Mesalazine—Crohn's disease	0.00132	0.00278	CcSEcCtD
Mirtazapine—HTR2B—lymph node—Crohn's disease	0.0013	0.0052	CbGeAlD
Mirtazapine—Neutropenia—Mesalazine—Crohn's disease	0.0013	0.00274	CcSEcCtD
Mirtazapine—Dysuria—Mesalazine—Crohn's disease	0.0013	0.00274	CcSEcCtD
Mirtazapine—Arthropathy—Prednisone—Crohn's disease	0.00129	0.00272	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00128	0.00271	CcSEcCtD
Mirtazapine—Pollakiuria—Mesalazine—Crohn's disease	0.00128	0.00271	CcSEcCtD
Mirtazapine—Agranulocytosis—Azathioprine—Crohn's disease	0.00127	0.00268	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00127	0.00268	CcSEcCtD
Mirtazapine—Decreased appetite—Mercaptopurine—Crohn's disease	0.00126	0.00267	CcSEcCtD
Mirtazapine—Weight increased—Mesalazine—Crohn's disease	0.00126	0.00267	CcSEcCtD
Mirtazapine—Weight decreased—Mesalazine—Crohn's disease	0.00126	0.00265	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00126	0.00265	CcSEcCtD
Mirtazapine—Pneumonia—Mesalazine—Crohn's disease	0.00124	0.00263	CcSEcCtD
Mirtazapine—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00124	0.00261	CcSEcCtD
Mirtazapine—Ulcer—Prednisone—Crohn's disease	0.00124	0.00261	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00123	0.00259	CcSEcCtD
Mirtazapine—HTR2A—digestive system—Crohn's disease	0.00122	0.00486	CbGeAlD
Mirtazapine—Stomatitis—Mesalazine—Crohn's disease	0.00121	0.00255	CcSEcCtD
Mirtazapine—Jaundice—Mesalazine—Crohn's disease	0.00121	0.00255	CcSEcCtD
Mirtazapine—Conjunctivitis—Mesalazine—Crohn's disease	0.0012	0.00254	CcSEcCtD
Mirtazapine—Urinary tract infection—Mesalazine—Crohn's disease	0.0012	0.00254	CcSEcCtD
Mirtazapine—Sweating—Mesalazine—Crohn's disease	0.00119	0.00251	CcSEcCtD
Mirtazapine—Haematuria—Mesalazine—Crohn's disease	0.00118	0.00249	CcSEcCtD
Mirtazapine—Hiccups—Prednisone—Crohn's disease	0.00117	0.00247	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00117	0.00247	CcSEcCtD
Mirtazapine—Epistaxis—Mesalazine—Crohn's disease	0.00117	0.00247	CcSEcCtD
Mirtazapine—Sinusitis—Mesalazine—Crohn's disease	0.00116	0.00245	CcSEcCtD
Mirtazapine—SLC6A2—lymph node—Crohn's disease	0.00116	0.00462	CbGeAlD
Mirtazapine—Agranulocytosis—Mesalazine—Crohn's disease	0.00115	0.00244	CcSEcCtD
Mirtazapine—Erythema multiforme—Azathioprine—Crohn's disease	0.00115	0.00244	CcSEcCtD
Mirtazapine—Body temperature increased—Mercaptopurine—Crohn's disease	0.00115	0.00243	CcSEcCtD
Mirtazapine—CYP3A4—digestive system—Crohn's disease	0.00113	0.0045	CbGeAlD
Mirtazapine—Rhinitis—Mesalazine—Crohn's disease	0.00111	0.00235	CcSEcCtD
Mirtazapine—Fluid retention—Prednisone—Crohn's disease	0.00111	0.00235	CcSEcCtD
Mirtazapine—Hepatitis—Mesalazine—Crohn's disease	0.00111	0.00235	CcSEcCtD
Mirtazapine—CYP2D6—digestive system—Crohn's disease	0.00111	0.00443	CbGeAlD
Mirtazapine—Pharyngitis—Mesalazine—Crohn's disease	0.0011	0.00233	CcSEcCtD
Mirtazapine—Urinary tract disorder—Mesalazine—Crohn's disease	0.0011	0.00232	CcSEcCtD
Mirtazapine—Oedema peripheral—Mesalazine—Crohn's disease	0.00109	0.00231	CcSEcCtD
Mirtazapine—Chills—Azathioprine—Crohn's disease	0.00109	0.00231	CcSEcCtD
Mirtazapine—Arrhythmia—Azathioprine—Crohn's disease	0.00109	0.0023	CcSEcCtD
Mirtazapine—Urethral disorder—Mesalazine—Crohn's disease	0.00109	0.0023	CcSEcCtD
Mirtazapine—Alopecia—Azathioprine—Crohn's disease	0.00108	0.00228	CcSEcCtD
Mirtazapine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00107	0.00226	CcSEcCtD
Mirtazapine—Erythema multiforme—Mesalazine—Crohn's disease	0.00105	0.00222	CcSEcCtD
Mirtazapine—Pulmonary oedema—Prednisone—Crohn's disease	0.00104	0.0022	CcSEcCtD
Mirtazapine—Eye disorder—Mesalazine—Crohn's disease	0.00104	0.00219	CcSEcCtD
Mirtazapine—Tinnitus—Mesalazine—Crohn's disease	0.00104	0.00219	CcSEcCtD
Mirtazapine—Cardiac disorder—Mesalazine—Crohn's disease	0.00103	0.00218	CcSEcCtD
Mirtazapine—ADRA2C—lymph node—Crohn's disease	0.00103	0.0041	CbGeAlD
Mirtazapine—Hyperkinesia—Prednisone—Crohn's disease	0.00102	0.00216	CcSEcCtD
Mirtazapine—Angiopathy—Mesalazine—Crohn's disease	0.00101	0.00213	CcSEcCtD
Mirtazapine—Euphoric mood—Prednisone—Crohn's disease	0.00101	0.00212	CcSEcCtD
Mirtazapine—Chills—Mesalazine—Crohn's disease	0.000997	0.00211	CcSEcCtD
Mirtazapine—Diarrhoea—Mercaptopurine—Crohn's disease	0.000995	0.0021	CcSEcCtD
Mirtazapine—Ill-defined disorder—Azathioprine—Crohn's disease	0.000985	0.00208	CcSEcCtD
Mirtazapine—Alopecia—Mesalazine—Crohn's disease	0.000981	0.00207	CcSEcCtD
Mirtazapine—Anaemia—Azathioprine—Crohn's disease	0.000981	0.00207	CcSEcCtD
Mirtazapine—Diabetes mellitus—Prednisone—Crohn's disease	0.000977	0.00206	CcSEcCtD
Mirtazapine—Mental disorder—Mesalazine—Crohn's disease	0.000973	0.00206	CcSEcCtD
Mirtazapine—Malaise—Azathioprine—Crohn's disease	0.000957	0.00202	CcSEcCtD
Mirtazapine—Flatulence—Mesalazine—Crohn's disease	0.000953	0.00201	CcSEcCtD
Mirtazapine—Leukopenia—Azathioprine—Crohn's disease	0.00095	0.00201	CcSEcCtD
Mirtazapine—Tension—Mesalazine—Crohn's disease	0.000949	0.002	CcSEcCtD
Mirtazapine—Dysgeusia—Mesalazine—Crohn's disease	0.000947	0.002	CcSEcCtD
Mirtazapine—Nervousness—Mesalazine—Crohn's disease	0.000939	0.00198	CcSEcCtD
Mirtazapine—Back pain—Mesalazine—Crohn's disease	0.000935	0.00198	CcSEcCtD
Mirtazapine—Vomiting—Mercaptopurine—Crohn's disease	0.000924	0.00195	CcSEcCtD
Mirtazapine—Rash—Mercaptopurine—Crohn's disease	0.000917	0.00194	CcSEcCtD
Mirtazapine—Dermatitis—Mercaptopurine—Crohn's disease	0.000916	0.00194	CcSEcCtD
Mirtazapine—Tremor—Mesalazine—Crohn's disease	0.000906	0.00191	CcSEcCtD
Mirtazapine—Increased appetite—Prednisone—Crohn's disease	0.000904	0.00191	CcSEcCtD
Mirtazapine—Amnesia—Prednisone—Crohn's disease	0.000904	0.00191	CcSEcCtD
Mirtazapine—Myalgia—Azathioprine—Crohn's disease	0.000904	0.00191	CcSEcCtD
Mirtazapine—Arthralgia—Azathioprine—Crohn's disease	0.000904	0.00191	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000897	0.0019	CcSEcCtD
Mirtazapine—Ill-defined disorder—Mesalazine—Crohn's disease	0.000897	0.0019	CcSEcCtD
Mirtazapine—Anaemia—Mesalazine—Crohn's disease	0.000894	0.00189	CcSEcCtD
Mirtazapine—Discomfort—Azathioprine—Crohn's disease	0.000893	0.00189	CcSEcCtD
Mirtazapine—Malaise—Mesalazine—Crohn's disease	0.000872	0.00184	CcSEcCtD
Mirtazapine—Vertigo—Mesalazine—Crohn's disease	0.000869	0.00184	CcSEcCtD
Mirtazapine—Syncope—Mesalazine—Crohn's disease	0.000867	0.00183	CcSEcCtD
Mirtazapine—Lethargy—Prednisone—Crohn's disease	0.000867	0.00183	CcSEcCtD
Mirtazapine—Leukopenia—Mesalazine—Crohn's disease	0.000865	0.00183	CcSEcCtD
Mirtazapine—Nausea—Mercaptopurine—Crohn's disease	0.000864	0.00182	CcSEcCtD
Mirtazapine—Infection—Azathioprine—Crohn's disease	0.000861	0.00182	CcSEcCtD
Mirtazapine—Palpitations—Mesalazine—Crohn's disease	0.000854	0.00181	CcSEcCtD
Mirtazapine—Loss of consciousness—Mesalazine—Crohn's disease	0.00085	0.0018	CcSEcCtD
Mirtazapine—Osteoarthritis—Prednisone—Crohn's disease	0.000849	0.00179	CcSEcCtD
Mirtazapine—Thrombocytopenia—Azathioprine—Crohn's disease	0.000848	0.00179	CcSEcCtD
Mirtazapine—Cough—Mesalazine—Crohn's disease	0.000844	0.00178	CcSEcCtD
Mirtazapine—Skin disorder—Azathioprine—Crohn's disease	0.000841	0.00178	CcSEcCtD
Mirtazapine—Affect lability—Prednisone—Crohn's disease	0.000836	0.00177	CcSEcCtD
Mirtazapine—Hypertension—Mesalazine—Crohn's disease	0.000835	0.00176	CcSEcCtD
Mirtazapine—HRH1—lymph node—Crohn's disease	0.000833	0.00333	CbGeAlD
Mirtazapine—Psychotic disorder—Prednisone—Crohn's disease	0.00083	0.00175	CcSEcCtD
Mirtazapine—Myalgia—Mesalazine—Crohn's disease	0.000823	0.00174	CcSEcCtD
Mirtazapine—Arthralgia—Mesalazine—Crohn's disease	0.000823	0.00174	CcSEcCtD
Mirtazapine—Chest pain—Mesalazine—Crohn's disease	0.000823	0.00174	CcSEcCtD
Mirtazapine—Anxiety—Mesalazine—Crohn's disease	0.00082	0.00173	CcSEcCtD
Mirtazapine—Face oedema—Prednisone—Crohn's disease	0.00082	0.00173	CcSEcCtD
Mirtazapine—ADRA2A—lymph node—Crohn's disease	0.000818	0.00327	CbGeAlD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000817	0.00173	CcSEcCtD
Mirtazapine—Discomfort—Mesalazine—Crohn's disease	0.000813	0.00172	CcSEcCtD
Mirtazapine—Hypotension—Azathioprine—Crohn's disease	0.000809	0.00171	CcSEcCtD
Mirtazapine—Dry mouth—Mesalazine—Crohn's disease	0.000805	0.0017	CcSEcCtD
Mirtazapine—Mood swings—Prednisone—Crohn's disease	0.000805	0.0017	CcSEcCtD
Mirtazapine—Confusional state—Mesalazine—Crohn's disease	0.000796	0.00168	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000789	0.00167	CcSEcCtD
Mirtazapine—Oedema—Mesalazine—Crohn's disease	0.000789	0.00167	CcSEcCtD
Mirtazapine—Infection—Mesalazine—Crohn's disease	0.000784	0.00166	CcSEcCtD
Mirtazapine—Dry skin—Prednisone—Crohn's disease	0.000779	0.00165	CcSEcCtD
Mirtazapine—Shock—Mesalazine—Crohn's disease	0.000776	0.00164	CcSEcCtD
Mirtazapine—Nervous system disorder—Mesalazine—Crohn's disease	0.000774	0.00164	CcSEcCtD
Mirtazapine—Thrombocytopenia—Mesalazine—Crohn's disease	0.000773	0.00163	CcSEcCtD
Mirtazapine—Tachycardia—Mesalazine—Crohn's disease	0.00077	0.00163	CcSEcCtD
Mirtazapine—Skin disorder—Mesalazine—Crohn's disease	0.000766	0.00162	CcSEcCtD
Mirtazapine—Hyperhidrosis—Mesalazine—Crohn's disease	0.000763	0.00161	CcSEcCtD
Mirtazapine—Anorexia—Mesalazine—Crohn's disease	0.000752	0.00159	CcSEcCtD
Mirtazapine—Muscular weakness—Prednisone—Crohn's disease	0.000749	0.00158	CcSEcCtD
Mirtazapine—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000749	0.00158	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000748	0.00158	CcSEcCtD
Mirtazapine—Abdominal distension—Prednisone—Crohn's disease	0.000739	0.00156	CcSEcCtD
Mirtazapine—Hypotension—Mesalazine—Crohn's disease	0.000737	0.00156	CcSEcCtD
Mirtazapine—Pancreatitis—Prednisone—Crohn's disease	0.00072	0.00152	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000719	0.00152	CcSEcCtD
Mirtazapine—Sweating increased—Prednisone—Crohn's disease	0.000715	0.00151	CcSEcCtD
Mirtazapine—Feeling abnormal—Azathioprine—Crohn's disease	0.000714	0.00151	CcSEcCtD
Mirtazapine—Insomnia—Mesalazine—Crohn's disease	0.000714	0.00151	CcSEcCtD
Mirtazapine—Paraesthesia—Mesalazine—Crohn's disease	0.000709	0.0015	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000708	0.0015	CcSEcCtD
Mirtazapine—Dyspnoea—Mesalazine—Crohn's disease	0.000704	0.00149	CcSEcCtD
Mirtazapine—Somnolence—Mesalazine—Crohn's disease	0.000702	0.00148	CcSEcCtD
Mirtazapine—Dyspepsia—Mesalazine—Crohn's disease	0.000695	0.00147	CcSEcCtD
Mirtazapine—Neutropenia—Prednisone—Crohn's disease	0.000687	0.00145	CcSEcCtD
Mirtazapine—Decreased appetite—Mesalazine—Crohn's disease	0.000686	0.00145	CcSEcCtD
Mirtazapine—Abdominal pain—Azathioprine—Crohn's disease	0.000685	0.00145	CcSEcCtD
Mirtazapine—Body temperature increased—Azathioprine—Crohn's disease	0.000685	0.00145	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000681	0.00144	CcSEcCtD
Mirtazapine—Fatigue—Mesalazine—Crohn's disease	0.00068	0.00144	CcSEcCtD
Mirtazapine—Erectile dysfunction—Prednisone—Crohn's disease	0.000676	0.00143	CcSEcCtD
Mirtazapine—Pain—Mesalazine—Crohn's disease	0.000675	0.00143	CcSEcCtD
Mirtazapine—Constipation—Mesalazine—Crohn's disease	0.000675	0.00143	CcSEcCtD
Mirtazapine—Weight increased—Prednisone—Crohn's disease	0.000668	0.00141	CcSEcCtD
Mirtazapine—Weight decreased—Prednisone—Crohn's disease	0.000664	0.0014	CcSEcCtD
Mirtazapine—Feeling abnormal—Mesalazine—Crohn's disease	0.00065	0.00137	CcSEcCtD
Mirtazapine—Acute coronary syndrome—Prednisone—Crohn's disease	0.000645	0.00136	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000645	0.00136	CcSEcCtD
Mirtazapine—Myocardial infarction—Prednisone—Crohn's disease	0.000642	0.00136	CcSEcCtD
Mirtazapine—Hypersensitivity—Azathioprine—Crohn's disease	0.000638	0.00135	CcSEcCtD
Mirtazapine—Urticaria—Mesalazine—Crohn's disease	0.000627	0.00132	CcSEcCtD
Mirtazapine—Abdominal pain—Mesalazine—Crohn's disease	0.000624	0.00132	CcSEcCtD
Mirtazapine—Body temperature increased—Mesalazine—Crohn's disease	0.000624	0.00132	CcSEcCtD
Mirtazapine—Bradycardia—Prednisone—Crohn's disease	0.000598	0.00126	CcSEcCtD
Mirtazapine—Diarrhoea—Azathioprine—Crohn's disease	0.000593	0.00125	CcSEcCtD
Mirtazapine—Hallucination—Prednisone—Crohn's disease	0.000585	0.00124	CcSEcCtD
Mirtazapine—Hypersensitivity—Mesalazine—Crohn's disease	0.000581	0.00123	CcSEcCtD
Mirtazapine—Dizziness—Azathioprine—Crohn's disease	0.000573	0.00121	CcSEcCtD
Mirtazapine—Asthenia—Mesalazine—Crohn's disease	0.000566	0.0012	CcSEcCtD
Mirtazapine—Pruritus—Mesalazine—Crohn's disease	0.000558	0.00118	CcSEcCtD
Mirtazapine—Vomiting—Azathioprine—Crohn's disease	0.000551	0.00116	CcSEcCtD
Mirtazapine—Eye disorder—Prednisone—Crohn's disease	0.000549	0.00116	CcSEcCtD
Mirtazapine—Rash—Azathioprine—Crohn's disease	0.000546	0.00115	CcSEcCtD
Mirtazapine—Dermatitis—Azathioprine—Crohn's disease	0.000546	0.00115	CcSEcCtD
Mirtazapine—Headache—Azathioprine—Crohn's disease	0.000543	0.00115	CcSEcCtD
Mirtazapine—Diarrhoea—Mesalazine—Crohn's disease	0.00054	0.00114	CcSEcCtD
Mirtazapine—Angiopathy—Prednisone—Crohn's disease	0.000533	0.00113	CcSEcCtD
Mirtazapine—Arrhythmia—Prednisone—Crohn's disease	0.000525	0.00111	CcSEcCtD
Mirtazapine—Dizziness—Mesalazine—Crohn's disease	0.000522	0.0011	CcSEcCtD
Mirtazapine—Alopecia—Prednisone—Crohn's disease	0.000519	0.0011	CcSEcCtD
Mirtazapine—Mental disorder—Prednisone—Crohn's disease	0.000515	0.00109	CcSEcCtD
Mirtazapine—Nausea—Azathioprine—Crohn's disease	0.000515	0.00109	CcSEcCtD
Mirtazapine—Malnutrition—Prednisone—Crohn's disease	0.000512	0.00108	CcSEcCtD
Mirtazapine—Vomiting—Mesalazine—Crohn's disease	0.000502	0.00106	CcSEcCtD
Mirtazapine—Rash—Mesalazine—Crohn's disease	0.000498	0.00105	CcSEcCtD
Mirtazapine—Dermatitis—Mesalazine—Crohn's disease	0.000497	0.00105	CcSEcCtD
Mirtazapine—Headache—Mesalazine—Crohn's disease	0.000494	0.00104	CcSEcCtD
Mirtazapine—Ill-defined disorder—Prednisone—Crohn's disease	0.000475	0.001	CcSEcCtD
Mirtazapine—Anaemia—Prednisone—Crohn's disease	0.000473	0.000999	CcSEcCtD
Mirtazapine—Agitation—Prednisone—Crohn's disease	0.00047	0.000993	CcSEcCtD
Mirtazapine—Nausea—Mesalazine—Crohn's disease	0.000469	0.00099	CcSEcCtD
Mirtazapine—Malaise—Prednisone—Crohn's disease	0.000461	0.000975	CcSEcCtD
Mirtazapine—Vertigo—Prednisone—Crohn's disease	0.00046	0.000971	CcSEcCtD
Mirtazapine—Syncope—Prednisone—Crohn's disease	0.000459	0.000969	CcSEcCtD
Mirtazapine—Loss of consciousness—Prednisone—Crohn's disease	0.00045	0.00095	CcSEcCtD
Mirtazapine—Convulsion—Prednisone—Crohn's disease	0.000443	0.000936	CcSEcCtD
Mirtazapine—Hypertension—Prednisone—Crohn's disease	0.000442	0.000933	CcSEcCtD
Mirtazapine—Arthralgia—Prednisone—Crohn's disease	0.000436	0.00092	CcSEcCtD
Mirtazapine—Myalgia—Prednisone—Crohn's disease	0.000436	0.00092	CcSEcCtD
Mirtazapine—Anxiety—Prednisone—Crohn's disease	0.000434	0.000917	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000433	0.000914	CcSEcCtD
Mirtazapine—Discomfort—Prednisone—Crohn's disease	0.00043	0.000909	CcSEcCtD
Mirtazapine—Oedema—Prednisone—Crohn's disease	0.000418	0.000882	CcSEcCtD
Mirtazapine—Infection—Prednisone—Crohn's disease	0.000415	0.000876	CcSEcCtD
Mirtazapine—Shock—Prednisone—Crohn's disease	0.000411	0.000868	CcSEcCtD
Mirtazapine—Nervous system disorder—Prednisone—Crohn's disease	0.000409	0.000865	CcSEcCtD
Mirtazapine—Tachycardia—Prednisone—Crohn's disease	0.000407	0.000861	CcSEcCtD
Mirtazapine—Skin disorder—Prednisone—Crohn's disease	0.000406	0.000857	CcSEcCtD
Mirtazapine—Hyperhidrosis—Prednisone—Crohn's disease	0.000404	0.000853	CcSEcCtD
Mirtazapine—Anorexia—Prednisone—Crohn's disease	0.000398	0.000841	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00038	0.000804	CcSEcCtD
Mirtazapine—Insomnia—Prednisone—Crohn's disease	0.000378	0.000798	CcSEcCtD
Mirtazapine—Paraesthesia—Prednisone—Crohn's disease	0.000375	0.000792	CcSEcCtD
Mirtazapine—Dyspepsia—Prednisone—Crohn's disease	0.000368	0.000777	CcSEcCtD
Mirtazapine—Decreased appetite—Prednisone—Crohn's disease	0.000363	0.000767	CcSEcCtD
Mirtazapine—Fatigue—Prednisone—Crohn's disease	0.00036	0.000761	CcSEcCtD
Mirtazapine—Constipation—Prednisone—Crohn's disease	0.000357	0.000754	CcSEcCtD
Mirtazapine—Feeling abnormal—Prednisone—Crohn's disease	0.000344	0.000727	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000341	0.000721	CcSEcCtD
Mirtazapine—Urticaria—Prednisone—Crohn's disease	0.000332	0.000701	CcSEcCtD
Mirtazapine—Abdominal pain—Prednisone—Crohn's disease	0.00033	0.000697	CcSEcCtD
Mirtazapine—Body temperature increased—Prednisone—Crohn's disease	0.00033	0.000697	CcSEcCtD
Mirtazapine—Hypersensitivity—Prednisone—Crohn's disease	0.000308	0.00065	CcSEcCtD
Mirtazapine—Asthenia—Prednisone—Crohn's disease	0.0003	0.000633	CcSEcCtD
Mirtazapine—Pruritus—Prednisone—Crohn's disease	0.000295	0.000624	CcSEcCtD
Mirtazapine—Diarrhoea—Prednisone—Crohn's disease	0.000286	0.000604	CcSEcCtD
Mirtazapine—Dizziness—Prednisone—Crohn's disease	0.000276	0.000583	CcSEcCtD
Mirtazapine—Vomiting—Prednisone—Crohn's disease	0.000265	0.000561	CcSEcCtD
Mirtazapine—Rash—Prednisone—Crohn's disease	0.000263	0.000556	CcSEcCtD
Mirtazapine—Dermatitis—Prednisone—Crohn's disease	0.000263	0.000556	CcSEcCtD
Mirtazapine—Headache—Prednisone—Crohn's disease	0.000262	0.000553	CcSEcCtD
Mirtazapine—Nausea—Prednisone—Crohn's disease	0.000248	0.000524	CcSEcCtD
Mirtazapine—OPRK1—Signaling by GPCR—CXCL8—Crohn's disease	4.21e-05	0.000153	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL3—Crohn's disease	4.2e-05	0.000152	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	4.2e-05	0.000152	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—RIPK2—Crohn's disease	4.19e-05	0.000152	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—RASGRP1—Crohn's disease	4.18e-05	0.000151	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR downstream signaling—CXCL8—Crohn's disease	4.17e-05	0.000151	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—JAK2—Crohn's disease	4.15e-05	0.00015	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—CXCL8—Crohn's disease	4.15e-05	0.00015	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—SMAD3—Crohn's disease	4.13e-05	0.000149	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—GCKR—Crohn's disease	4.12e-05	0.000149	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL3—Crohn's disease	4.09e-05	0.000148	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—RASGRP1—Crohn's disease	4.09e-05	0.000148	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—GCKR—Crohn's disease	4.08e-05	0.000148	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	4.07e-05	0.000147	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL2RA—Crohn's disease	4.06e-05	0.000147	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—TYK2—Crohn's disease	4.05e-05	0.000147	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	4.01e-05	0.000145	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL2RA—Crohn's disease	4e-05	0.000145	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—CXCL8—Crohn's disease	3.97e-05	0.000144	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—RASGRP1—Crohn's disease	3.96e-05	0.000143	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—SMAD3—Crohn's disease	3.94e-05	0.000143	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	3.94e-05	0.000143	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	3.92e-05	0.000142	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	3.9e-05	0.000141	CbGpPWpGaD
Mirtazapine—DRD3—GPCR downstream signaling—CXCL8—Crohn's disease	3.88e-05	0.000141	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—JAK2—Crohn's disease	3.88e-05	0.00014	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—SOCS1—Crohn's disease	3.87e-05	0.00014	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—JAK2—Crohn's disease	3.87e-05	0.00014	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	3.86e-05	0.00014	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—FADS1—Crohn's disease	3.86e-05	0.00014	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	3.85e-05	0.000139	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL2RA—Crohn's disease	3.82e-05	0.000138	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—MTMR3—Crohn's disease	3.82e-05	0.000138	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—STAT3—Crohn's disease	3.81e-05	0.000138	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—RIPK2—Crohn's disease	3.81e-05	0.000138	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—JAK2—Crohn's disease	3.79e-05	0.000137	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—CXCL8—Crohn's disease	3.79e-05	0.000137	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—SOCS1—Crohn's disease	3.79e-05	0.000137	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	3.78e-05	0.000137	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	3.74e-05	0.000135	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—RIPK2—Crohn's disease	3.74e-05	0.000135	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL3—Crohn's disease	3.71e-05	0.000134	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	3.71e-05	0.000134	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	3.7e-05	0.000134	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—TYK2—Crohn's disease	3.69e-05	0.000134	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	3.69e-05	0.000134	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	3.68e-05	0.000133	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—SMAD3—Crohn's disease	3.67e-05	0.000133	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	3.67e-05	0.000133	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL3—Crohn's disease	3.65e-05	0.000132	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL2RA—Crohn's disease	3.65e-05	0.000132	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL3—Crohn's disease	3.64e-05	0.000132	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GPX4—Crohn's disease	3.61e-05	0.000131	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—TYK2—Crohn's disease	3.61e-05	0.000131	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—JAK2—Crohn's disease	3.59e-05	0.00013	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	3.59e-05	0.00013	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.59e-05	0.00013	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—SOCS1—Crohn's disease	3.58e-05	0.00013	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL3—Crohn's disease	3.57e-05	0.000129	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—CXCL8—Crohn's disease	3.54e-05	0.000128	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	3.53e-05	0.000128	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	3.53e-05	0.000128	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—CXCL8—Crohn's disease	3.53e-05	0.000128	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	3.52e-05	0.000128	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—JAK2—Crohn's disease	3.52e-05	0.000127	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	3.51e-05	0.000127	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	3.51e-05	0.000127	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GCKR—Crohn's disease	3.49e-05	0.000126	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—CXCL8—Crohn's disease	3.46e-05	0.000125	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	3.46e-05	0.000125	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—JAK2—Crohn's disease	3.44e-05	0.000125	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—TYK2—Crohn's disease	3.42e-05	0.000124	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	3.41e-05	0.000123	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL2RA—Crohn's disease	3.4e-05	0.000123	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	3.39e-05	0.000123	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	3.37e-05	0.000122	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	3.37e-05	0.000122	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	3.35e-05	0.000121	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—SMAD3—Crohn's disease	3.34e-05	0.000121	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL3—Crohn's disease	3.32e-05	0.00012	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—CXCL8—Crohn's disease	3.28e-05	0.000119	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—SMAD3—Crohn's disease	3.27e-05	0.000118	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—JAK2—Crohn's disease	3.26e-05	0.000118	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	3.26e-05	0.000118	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SOCS1—Crohn's disease	3.25e-05	0.000118	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—CXCL8—Crohn's disease	3.21e-05	0.000116	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	3.21e-05	0.000116	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	3.2e-05	0.000116	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	3.2e-05	0.000116	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	3.2e-05	0.000116	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	3.2e-05	0.000116	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SOCS1—Crohn's disease	3.19e-05	0.000116	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	3.18e-05	0.000115	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—CXCL8—Crohn's disease	3.14e-05	0.000114	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	3.14e-05	0.000114	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.14e-05	0.000114	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	3.13e-05	0.000113	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—TYK2—Crohn's disease	3.1e-05	0.000112	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL2RA—Crohn's disease	3.1e-05	0.000112	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—SMAD3—Crohn's disease	3.09e-05	0.000112	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	3.07e-05	0.000111	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	3.06e-05	0.000111	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	3.05e-05	0.00011	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—TYK2—Crohn's disease	3.04e-05	0.00011	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL2RA—Crohn's disease	3.03e-05	0.00011	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	2.99e-05	0.000108	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—FADS1—Crohn's disease	2.98e-05	0.000108	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—CXCL8—Crohn's disease	2.97e-05	0.000108	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	2.97e-05	0.000108	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	2.96e-05	0.000107	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—JAK2—Crohn's disease	2.96e-05	0.000107	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	2.95e-05	0.000107	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	2.92e-05	0.000106	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	2.92e-05	0.000106	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.92e-05	0.000106	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	2.92e-05	0.000106	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	2.91e-05	0.000105	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	2.91e-05	0.000105	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—JAK2—Crohn's disease	2.9e-05	0.000105	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL2RA—Crohn's disease	2.86e-05	0.000104	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	2.86e-05	0.000104	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TYK2—Crohn's disease	2.86e-05	0.000103	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	2.85e-05	0.000103	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TYK2—Crohn's disease	2.81e-05	0.000102	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SMAD3—Crohn's disease	2.81e-05	0.000102	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GPX4—Crohn's disease	2.79e-05	0.000101	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	2.78e-05	0.0001	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	2.76e-05	0.0001	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SMAD3—Crohn's disease	2.76e-05	9.97e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—JAK2—Crohn's disease	2.73e-05	9.87e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	2.7e-05	9.79e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	2.7e-05	9.77e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TYK2—Crohn's disease	2.69e-05	9.75e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GCKR—Crohn's disease	2.69e-05	9.75e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—JAK2—Crohn's disease	2.69e-05	9.72e-05	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—IL6—Crohn's disease	2.66e-05	9.63e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	2.66e-05	9.63e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	2.66e-05	9.61e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	2.65e-05	9.59e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	2.65e-05	9.58e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	2.6e-05	9.41e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL2RA—Crohn's disease	2.6e-05	9.41e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TYK2—Crohn's disease	2.57e-05	9.31e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—JAK2—Crohn's disease	2.57e-05	9.3e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	2.56e-05	9.26e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.55e-05	9.24e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL2RA—Crohn's disease	2.55e-05	9.24e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	2.51e-05	9.09e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	2.5e-05	9.06e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.49e-05	9.02e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—CXCL8—Crohn's disease	2.49e-05	9.01e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—ALB—Crohn's disease	2.48e-05	8.96e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—JAK2—Crohn's disease	2.45e-05	8.88e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CXCL8—Crohn's disease	2.45e-05	8.87e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	2.42e-05	8.74e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TYK2—Crohn's disease	2.39e-05	8.66e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—IL6—Crohn's disease	2.37e-05	8.57e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CXCL8—Crohn's disease	2.35e-05	8.49e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—IL6—Crohn's disease	2.33e-05	8.43e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	2.33e-05	8.42e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—JAK2—Crohn's disease	2.28e-05	8.26e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CXCL8—Crohn's disease	2.24e-05	8.1e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—IL6—Crohn's disease	2.23e-05	8.07e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.18e-05	7.9e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TYK2—Crohn's disease	2.18e-05	7.89e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PTGS2—Crohn's disease	2.17e-05	7.84e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TYK2—Crohn's disease	2.13e-05	7.72e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—IL6—Crohn's disease	2.13e-05	7.71e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TYK2—Crohn's disease	2.09e-05	7.55e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CXCL8—Crohn's disease	2.08e-05	7.54e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—JAK2—Crohn's disease	2.08e-05	7.53e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TYK2—Crohn's disease	2.08e-05	7.51e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—JAK2—Crohn's disease	2.04e-05	7.36e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TYK2—Crohn's disease	2.02e-05	7.3e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—ALB—Crohn's disease	2.01e-05	7.28e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—STAT3—Crohn's disease	2e-05	7.25e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—JAK2—Crohn's disease	1.99e-05	7.2e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—IL6—Crohn's disease	1.98e-05	7.17e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—JAK2—Crohn's disease	1.98e-05	7.16e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—STAT3—Crohn's disease	1.97e-05	7.13e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—JAK2—Crohn's disease	1.93e-05	6.97e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CXCL8—Crohn's disease	1.9e-05	6.87e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—STAT3—Crohn's disease	1.89e-05	6.83e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CXCL8—Crohn's disease	1.86e-05	6.72e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TYK2—Crohn's disease	1.83e-05	6.63e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	1.82e-05	6.57e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	1.81e-05	6.54e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—IL6—Crohn's disease	1.81e-05	6.53e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TYK2—Crohn's disease	1.8e-05	6.52e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—STAT3—Crohn's disease	1.8e-05	6.52e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TYK2—Crohn's disease	1.8e-05	6.51e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—IL6—Crohn's disease	1.77e-05	6.39e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	1.76e-05	6.39e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTGS2—Crohn's disease	1.76e-05	6.37e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CXCL8—Crohn's disease	1.76e-05	6.36e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—JAK2—Crohn's disease	1.75e-05	6.32e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—IL6—Crohn's disease	1.73e-05	6.25e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—JAK2—Crohn's disease	1.72e-05	6.22e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—IL6—Crohn's disease	1.72e-05	6.22e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—JAK2—Crohn's disease	1.72e-05	6.21e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	1.68e-05	6.09e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—STAT3—Crohn's disease	1.68e-05	6.06e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—IL6—Crohn's disease	1.67e-05	6.05e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	1.64e-05	5.93e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—ALB—Crohn's disease	1.6e-05	5.78e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CXCL8—Crohn's disease	1.59e-05	5.77e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	1.57e-05	5.68e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CXCL8—Crohn's disease	1.57e-05	5.67e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	1.56e-05	5.66e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	1.54e-05	5.56e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—STAT3—Crohn's disease	1.53e-05	5.53e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL6—Crohn's disease	1.52e-05	5.49e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—STAT3—Crohn's disease	1.49e-05	5.41e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL6—Crohn's disease	1.49e-05	5.4e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL6—Crohn's disease	1.49e-05	5.39e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	1.46e-05	5.29e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—STAT3—Crohn's disease	1.46e-05	5.29e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—STAT3—Crohn's disease	1.45e-05	5.26e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	1.43e-05	5.17e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—STAT3—Crohn's disease	1.41e-05	5.11e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—Crohn's disease	1.4e-05	5.06e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—Crohn's disease	1.4e-05	5.06e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—Crohn's disease	1.38e-05	4.98e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	1.36e-05	4.91e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—Crohn's disease	1.32e-05	4.77e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ALB—Crohn's disease	1.31e-05	4.74e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ALB—Crohn's disease	1.3e-05	4.7e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—STAT3—Crohn's disease	1.28e-05	4.64e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—STAT3—Crohn's disease	1.26e-05	4.57e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—STAT3—Crohn's disease	1.26e-05	4.56e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—Crohn's disease	1.26e-05	4.55e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	1.24e-05	4.47e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—Crohn's disease	1.17e-05	4.24e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	1.15e-05	4.15e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—Crohn's disease	1.15e-05	4.15e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—Crohn's disease	1.14e-05	4.11e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ALB—Crohn's disease	1.11e-05	4.02e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—Crohn's disease	1.07e-05	3.86e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—Crohn's disease	1.04e-05	3.78e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—Crohn's disease	1.02e-05	3.69e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—Crohn's disease	1.01e-05	3.67e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—Crohn's disease	9.87e-06	3.57e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—Crohn's disease	9.72e-06	3.52e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—Crohn's disease	8.96e-06	3.24e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—Crohn's disease	8.81e-06	3.19e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—Crohn's disease	8.79e-06	3.18e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—Crohn's disease	8.63e-06	3.12e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ALB—Crohn's disease	8.57e-06	3.1e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—Crohn's disease	8.02e-06	2.9e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—Crohn's disease	7.5e-06	2.71e-05	CbGpPWpGaD
